期刊文献+

基于Box-Behnken Design设计优化白藜芦醇纳米混悬剂的制备工艺 被引量:5

Optimization of preparation process of resveratrol nanosuspension based on Box-Behnken Design
下载PDF
导出
摘要 目的优化白藜芦醇纳米混悬剂的最佳制备工艺。方法采用反溶剂沉淀法制备白藜芦醇纳米混悬剂,以聚乙烯吡咯烷酮PVPK 17 PF为助悬剂,泊洛沙姆F188为表面活性剂,以粒径及多分散指数为响应值,应用Box-Behnken Design响应面实验设计优化白藜芦醇纳米混悬剂的最佳处方,并采用桨法进行体外释放实验评价其药物释放特征。结果优化后的纳米混悬剂处方为:白藜芦醇的质量浓度为29.2 mg/mL,助悬剂PVP K17PF的质量分数为0.38%,表面活性剂Poloxmer 188质量浓度为3.63 mg/mL。所制备纳米混悬剂的粒径大小为145 nm左右,在1 h的累积释放接近80%,释放机制为扩散作用为主。结论将白藜芦醇制备成纳米混悬剂可以提高白藜芦醇的溶出度,为难溶性药物白藜芦醇的进一步开发奠定了基础。 Objective To optimize the best preparation process of resveratrol nanosuspension.Methods Resveratrol nanosuspension was prepared by antisolvent precipitation method with polyvinyl pyrrolidone PVP17PF as suspension agent and poloxamer F188 as surfactant.The optimized formulation of resveratrol nanosuspension was screeed by Box-Behnken Design(BBD)response surface experiment with particle size and polydispersity index as response values.The drug release characteristics of resveratrol nanosuspension was evaluated by paddle method in vitro.Results The optimized formulation of resveratrol nanosuspension was as follows:the content of resveratrol was 29.2 mg/mL,the ratio of PVP K17PF was 0.38%and the concentration of Poloxmer 188 was 3.63 mg/mL.The particle size of prepared resveratrol nanosuspension was about 145 nm.The cumulative release of resveratrol nanosuspension in 1 h was close to 80%.The release mechanism was dominated by diffusion.Conclusion The preparation of resveratrol nanosuspension may improve the dissolution of resveratrol,which can lay a foundation for the further development of insoluble drug resveratrol.
作者 王鸿森 贾晓凡 徐彦浩 常晟 李丽 赵静 郝吉福 WANG Hongsen;JIA Xiaofan;XU Yanhao;CHANG Sheng;LI Li;ZHAO Jing;HAO Jifu*(Department of Pharmaceutics,Shandong First Medical University&Shandong Academy of Medical Sciences,Taian 271016,China;Taishan Sanatorium of Shandong Province(Shandong Taishan Hospital),Taian 271016,China)
出处 《广东药科大学学报》 CAS 2020年第3期315-321,共7页 Journal of Guangdong Pharmaceutical University
基金 2016年国家级大学生创新创业训练计划项目(201610439108) 山东省中医药科技发展计划项目(2017-240)。
关键词 白藜芦醇 纳米混悬剂 Box-Behnken Design响应面设计 反溶剂沉淀法 resveratrol nanosuspension Box-Behnken surface responsed design antisolvent precipitation method
  • 相关文献

参考文献4

二级参考文献35

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2熊若兰,陆伟根.纳米混悬剂研究进展[J].世界临床药物,2007,28(2):117-121. 被引量:14
  • 3邱仁祖.锆对机体免疫毒性的实验研究[J].国外医学·卫生学分册,1989,16(3):52.
  • 4KECK C M,MLLER R H.Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation[J].European Joural of Pharmaceatics and Biopharmaceutics,2006,62(1):3-16.
  • 5APTE S P,UGWU S O.A review and classification of emerging excipients in parenteral medications[J].Pharm Tec,2003,27(3):46-60.
  • 6CABANE H,LAPORTE D,PROVOST A.An experimental study of Ostwald ripening of olivine and plagioclase in silicate melts:implications for the growth and size of crystals in magmas[J].Contrib Miner Petrol,2005,150(1):37-53.
  • 7SHEN L,GUO A,ZHU X Y.Tween surfactants:Adsorption,self-organization,and protein resistance[J].Surf Sc,2011,605(5/6):494-499.
  • 8COCHRAN K W,DOULL J,MAZUR M,et al.Acute toxicity of zirconium,columbium,strontium,lanthanum,cesium,tantalum and yttrium[J].Arch Ind Hyg Occup Med,1950,1(6):637-650.
  • 9JUHNKE M M,RTIN D,JOHN E,et al.Generation of wear during the production of drug nanosuspensions by wet media milling[J].European Journal of Pharmaceutics and Biopharmaceutics,2012,81(1):214-222.
  • 10GHOSH S,SHARMA A,TALUKDER Z.An abnormal trace element in biology[J].Biological Trace Element Research,1992,35(3):247-271.

共引文献20

同被引文献86

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部